Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Breast Cancer Screening Advice Confusing Following Cancer Society Update, Industry Says

This article was originally published in The Gray Sheet

Executive Summary

The American Cancer Society’s Oct. 20 update to breast cancer screening guidelines for mammograms starting at age 45, rather than its prior recommendation to start at age 40, for average risk women conflicts with other groups’ recommendations, is confusing and potential “risky”, say the imaging industry and some medical groups.


Related Content

House Members Seek More Transparency, Input For US Preventive Services Task Force
Task Force Mammography Guidelines Present Challenges And Opportunities


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts